-The European manufacturer of Plan B, aka the morning-after pill, will warn women that the drug is completely ineffective for women who weigh more than 176 pounds and begins to lose effectiveness in women who weigh more than 165 pounds.
-French manufacturer of the European drug, Norlevo, is changing its packaging information to reflect the weight limits. European pharmaceutical regulators approved the change on November 10, but it has not been previously reported.
-Plan B One-Step, Next Choice One Dose, and My Way, and a number of generic two-pill emergency contraceptives—have a dosage and chemical makeup identical to the European drug.
-American manufacturers do not currently advise American customers of weight limits for levonorgestrel-based emergency contraceptives.
- HRA Pharma spokeswoman. "However, women with higher weight are advised to discuss alternative emergency contraceptive options with their physician: IUD or alternative oral emergency contraceptive." (in the U.S, IUD insertion is between $500-$900)
- HRA Pharma sells Norlevo throughout most European countries, parts of China, parts of the Middle East, many Francophone African countries, Australia, Taiwan, and South Korea. Norlevo was also recently approved for sale in India.
-changes to Norlevo's labels will be "procedure and country-dependent" and adds that the company has no timetable for changing its product labels in non-European countries.
They are handing out leaflets however, beginning early in 2014 about the new updates. The newest changes are highlighted in this 8 page PDF.
Source at motherjones.com
(crossposted to a few other communities to spread the word about this)